Teresa Kam is a pharmacist who is specialized in Oncology in Chapel Hill, North Carolina. Patients can reach her at 101 Manning Dr, Cb 7600, Chapel Hill or contact her on 919-843-0346. Active license number of Teresa Kam is 22816 for Oncology in North Carolina. Teresa Kam is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Teresa Kam speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Teresa Kam
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
101 Manning Dr, Cb 7600, Chapel Hill, North Carolina, 27514-4220
Phone:
919-843-0346
Fax:
919-966-7163
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Teresa Kam are as mentioned below.
NPI Number:
1255677035
NPI Enumeration Date:
23 Dec, 2012
NPI Last Update On:
27 Dec, 2012
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Teresa Kam are as mentioned below.
Specialization
License Number
State
Status
Oncology
22816
North Carolina
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
101 Manning Dr, Cb 7600 Chapel Hill, North Carolina
Zip:
27514-4220
Phone Number:
--
Fax Number:
--
Patients can reach Teresa Kam at 101 Manning Dr, Cb 7600, Chapel Hill, North Carolina or can call on phone at 919-843-0346.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.